Global Retinal Drugs Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	167 Pages	TechNavio	January, 2023	INF17712990

Best Price Guarantee
Price	from $2,500
Length	167 Pages
Publisher	TechNavio
Published Date	January, 2023
SKU	INF17712990

Global Retinal Drugs Market 2023-2027

Technavio has been monitoring the retinal drugs market and is forecast to grow by $7275.79 mn during 2022-2027, accelerating at a CAGR of 6.27% during the forecast period. Our report on the retinal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in prevalence of retinal diseases, emergence of advanced diagnostic tools, and patient assistance programs.

Technavio's retinal drugs market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Indication

Macular degeneration
Diabetic eye disease
Others

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of innovative therapies as one of the prime reasons driving the retinal drugs market growth during the next few years. Also, rise in demand for sustained-release ocular formulations and advances in diagnostic techniques will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the retinal drugs market covers the following areas:

Retinal drugs market sizing
Retinal drugs market forecast
Retinal drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading retinal drugs market vendors that include Bayer AG, AbbVie Inc., Alcon Inc., Alimera Sciences Inc., Bausch Health Co Inc., Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Kubota Corp., MeiraGTx Holdings Plc, Novartis AG, Ocular Therapeutix Inc., Oxurion NV, Pfizer Inc., Regeneron Pharmaceuticals Inc., REGENXBIO Inc, Sanofi SA, Santen Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Visufarma, and Johnson and Johnson Services Inc. Also, the retinal drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Chart on Market Overview
  - Table Executive Summary - Data Table on Market Overview
  - Table Executive Summary - Chart on Global Market Characteristics
  - Table Executive Summary - Chart on Market by Geography
  - Table Executive Summary - Chart on Market Segmentation by Distribution Channel
  - Table Executive Summary - Chart on Market Segmentation by Indication
  - Table Executive Summary - Chart on Incremental Growth
  - Table Executive Summary - Data Table on Incremental Growth
  - Table Executive Summary - Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Global - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Global - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Historic Market Size
- Global retinal drugs market 2017 - 2021
  - Table Historic market size - Data table on global retinal drugs market 2017 - 2021 ($ million)
- Distribution channel Segment Analysis 2017 - 2021
  - Table Historic market size - Distribution channel segment 2017 - 2021 ($ million)
- Indication Segment Analysis 2017 - 2021
  - Table Historic market size - Indication segment 2017 - 2021 ($ million)
- Geography Segment Analysis 2017 - 2021
  - Table Historic market size - Geography segment 2017 - 2021 ($ million)
- Country Segment Analysis 2017 - 2021
  - Table Historic market size - Country segment 2017 - 2021 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers - Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants - Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes - Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry - Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Distribution Channel
- Market segments
  - Table Chart on Distribution Channel - Market share 2022-2027 (%)
  - Table Data Table on Distribution Channel - Market share 2022-2027 (%)
- Comparison by Distribution Channel
  - Table Chart on Comparison by Distribution Channel
  - Table Data Table on Comparison by Distribution Channel
- Hospital pharmacy - Market size and forecast 2022-2027
  - Table Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
- Retail pharmacy - Market size and forecast 2022-2027
  - Table Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
- Online pharmacy - Market size and forecast 2022-2027
  - Table Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
- Market opportunity by Distribution Channel
  - Table Market opportunity by Distribution Channel ($ million)
Market Segmentation by Indication
- Market segments
  - Table Chart on Indication - Market share 2022-2027 (%)
  - Table Data Table on Indication - Market share 2022-2027 (%)
- Comparison by Indication
  - Table Chart on Comparison by Indication
  - Table Data Table on Comparison by Indication
- Macular degeneration - Market size and forecast 2022-2027
  - Table Chart on Macular degeneration - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Macular degeneration - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Macular degeneration - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Macular degeneration - Year-over-year growth 2022-2027 (%)
- Diabetic eye disease - Market size and forecast 2022-2027
  - Table Chart on Diabetic eye disease - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Diabetic eye disease - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Diabetic eye disease - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Diabetic eye disease - Year-over-year growth 2022-2027 (%)
- Others - Market size and forecast 2022-2027
  - Table Chart on Others - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Others - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Others - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Others - Year-over-year growth 2022-2027 (%)
- Market opportunity by Indication
  - Table Market opportunity by Indication ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2022-2027 (%)
  - Table Data Table on Market share by geography 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2022-2027
  - Table Chart on North America - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on North America - Market size and forecast 2022-2027 ($ million)
  - Table Chart on North America - Year-over-year growth 2022-2027 (%)
  - Table Data Table on North America - Year-over-year growth 2022-2027 (%)
- Europe - Market size and forecast 2022-2027
  - Table Chart on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Europe - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Asia - Market size and forecast 2022-2027
  - Table Chart on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Asia - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Rest of World (ROW) - Market size and forecast 2022-2027
  - Table Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- US - Market size and forecast 2022-2027
  - Table Chart on US - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on US - Market size and forecast 2022-2027 ($ million)
  - Table Chart on US - Year-over-year growth 2022-2027 (%)
  - Table Data Table on US - Year-over-year growth 2022-2027 (%)
- China - Market size and forecast 2022-2027
  - Table Chart on China - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on China - Market size and forecast 2022-2027 ($ million)
  - Table Chart on China - Year-over-year growth 2022-2027 (%)
  - Table Data Table on China - Year-over-year growth 2022-2027 (%)
- Germany - Market size and forecast 2022-2027
  - Table Chart on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Germany - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Germany - Year-over-year growth 2022-2027 (%)
- Spain - Market size and forecast 2022-2027
  - Table Chart on Spain - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Spain - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Spain - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Spain - Year-over-year growth 2022-2027 (%)
- Canada - Market size and forecast 2022-2027
  - Table Chart on Canada - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Canada - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Canada - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Rise in prevalence of retinal diseases
  - Emergence of advanced diagnostic tools
  - Patient assistance programs
- Market challenges
  - High cost associated with retinal disease therapy
  - Limitations and risk factors associated with current retinal diseases treatment drugs
  - Limitations in current drug delivery methods and challenges in development of alternative methods
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - Development of innovative therapies
  - Rise in demand for sustained-release ocular formulations
  - Advances in diagnostic techniques
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key news
  - Table AbbVie Inc. - Key offerings
- Alcon Inc.
  - Table Alcon Inc. - Overview
  - Table Alcon Inc. - Business segments
  - Table Alcon Inc. - Key offerings
  - Table Alcon Inc. - Segment focus
- Alimera Sciences Inc.
  - Table Alimera Sciences Inc. - Overview
  - Table Alimera Sciences Inc. - Product / Service
  - Table Alimera Sciences Inc. - Key offerings
- Bausch Health Co Inc.
  - Table Bausch Health Co Inc. - Overview
  - Table Bausch Health Co Inc. - Business segments
  - Table Bausch Health Co Inc. - Key news
  - Table Bausch Health Co Inc. - Key offerings
  - Table Bausch Health Co Inc. - Segment focus
- Bayer AG
  - Table Bayer AG - Overview
  - Table Bayer AG - Business segments
  - Table Bayer AG - Key news
  - Table Bayer AG - Key offerings
  - Table Bayer AG - Segment focus
- Bristol Myers Squibb Co.
  - Table Bristol Myers Squibb Co. - Overview
  - Table Bristol Myers Squibb Co. - Product / Service
  - Table Bristol Myers Squibb Co. - Key news
  - Table Bristol Myers Squibb Co. - Key offerings
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- Johnson and Johnson Services Inc.
  - Table Johnson and Johnson Services Inc. - Overview
  - Table Johnson and Johnson Services Inc. - Business segments
  - Table Johnson and Johnson Services Inc. - Key news
  - Table Johnson and Johnson Services Inc. - Key offerings
  - Table Johnson and Johnson Services Inc. - Segment focus
- MeiraGTx Holdings Plc
  - Table MeiraGTx Holdings Plc - Overview
  - Table MeiraGTx Holdings Plc - Product / Service
  - Table MeiraGTx Holdings Plc - Key offerings
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Ocular Therapeutix Inc.
  - Table Ocular Therapeutix Inc. - Overview
  - Table Ocular Therapeutix Inc. - Product / Service
  - Table Ocular Therapeutix Inc. - Key offerings
- Oxurion NV
  - Table Oxurion NV - Overview
  - Table Oxurion NV - Product / Service
  - Table Oxurion NV - Key offerings
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Regeneron Pharmaceuticals Inc.
  - Table Regeneron Pharmaceuticals Inc. - Overview
  - Table Regeneron Pharmaceuticals Inc. - Product / Service
  - Table Regeneron Pharmaceuticals Inc. - Key offerings
- Sanofi SA
  - Table Sanofi SA - Overview
  - Table Sanofi SA - Business segments
  - Table Sanofi SA - Key news
  - Table Sanofi SA - Key offerings
  - Table Sanofi SA - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations